BackClever Leaves Holdings- Warrants (18/12/2025) Overview
Clever Leaves Holdings Inc - Warrants (18/12/2025)

Clever Leaves Holdings- Warrants (18/12/2025) Return on Equity

Valuation check: CLVRW's ROE is -62.09%, above the Healthcare sector average of -100.59%.

Get informed when a big investor buys or sells

+ Follow

ROE

-62.09%

Return on Equity

-62.09%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Clever Leaves Holdings- Warrants (18/12/2025) (CLVRW) FAQ

The latest ROE for CLVRW is -62.09%. That is above the Healthcare sector average of -100.59%. Investors often review this figure alongside Clever Leaves Holdings- Warrants (18/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, CLVRW currently prints -62.09% for ROE, while the sector average sits near -100.59%. That is roughly 38.3% above the sector mean. Large gaps often invite a closer look at Clever Leaves Holdings- Warrants (18/12/2025)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Clever Leaves Holdings- Warrants (18/12/2025) converts resources into returns. At -62.09%, CLVRW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CLVRW's ROE (-62.09%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Clever Leaves Holdings- Warrants (18/12/2025)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.